KMX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CarMax Inc (KMX) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock has shown strong positive momentum following its Q1 earnings report, which exceeded expectations. Analysts have upgraded their ratings and raised price targets, hedge funds are increasing their positions, and technical indicators are bullish. While there are some concerns about market share pressure and operational challenges, the company's focus on digital transformation and improving customer experience provides a solid foundation for long-term growth.
The MACD is positively expanding, indicating bullish momentum. The RSI is neutral at 68.392, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot level of 49.953, with resistance levels at 52.986 and 54.86, suggesting potential for further upside.
Q1 earnings beat expectations with $8.01 billion in revenue and $1.31 EPS.
Analysts have upgraded ratings and raised price targets, with the highest target at $
Hedge funds are significantly increasing their positions, with a 179.34% increase in buying activity.
The company is focusing on digital transformation and customer experience improvements, which are likely to drive long-term growth.
Some analysts remain cautious, citing market share pressure from competitors like Carvana.
Earnings per share declined 5.1% year-over-year, reflecting some operational challenges.
No recent congress trading data or insider buying activity to further validate confidence.
CarMax reported Q1 revenue of $8.01 billion, exceeding expectations. However, EPS declined 5.1% year-over-year, highlighting some ongoing challenges. The company is in the early stages of a turnaround, focusing on improving price competitiveness and customer experience.
Analysts are mixed but leaning positive. Stephens upgraded the stock to Overweight with a price target of $66, citing a favorable setup. Baird raised the target to $55, highlighting an early-stage turnaround. However, some analysts like JPMorgan and Barclays remain cautious, maintaining Underweight ratings due to competitive pressures and operational concerns.
